In vivo depletion of B cells using a combination of high- dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 729-735

  Voso, Maria Teresa ^a,c   Pantel, Gitta ^b   Weis, Mirjam ^b   Schmidt, Petra ^b   Martin, Simona ^b   Moos, Marion ^b   Ho, Anthony D ^b   Haas, Rainer ^a,b   Hohaus, Stefan ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Follicular lymphoma; Real time PCR; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; LYMPHOCYTE ANTIBODY; MITOXANTRONE; MONOCLONAL ANTIBODY CD20; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; LYMPHOCYTE DEPLETION; MALE; MANTLE CELL LYMPHOMA; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKAPHERESIS; LYMPHOCYTE DEPLETION; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MITOXANTRONE; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREDNISONE; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE; WHOLE-BODY IRRADIATION;

EID: 0033861062     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02084.x     Document Type: Article

References (23)

1. Bastion, Y., Brice, P., Haioun, C., Sonet, A., Salles, G., Marolleau, J.P., Espinouse, D., Reyes, F., Gisselbrecht, C. & Coiffier, B. (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma. Blood, 86, 3257-3262.
2. Buchsbaum, D.J., Wahl, R.L., Glenn, S.D., Normolle, D.P. & Kaminski, M.S. (1992) Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody. Cancer Research, 52, 637-642.
3. Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., LoBuglio, A.F., Jonas, C., Klippenstein, D., Dallaire, B. & Varns, C. (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. Journal of Clinical Oncology, 17, 268-276.
4. Dana, B.W., Dahlberg, S., Nathwani, B.N., Chase, E., Coltman, C., Miller, T.P. & Fisher, R.I. (1993) Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. Journal of Clinical Oncology, 11, 644-651.
5. Demidem, A., Lam, T., Alas, S., Hariharan, K., Hanna, N. & Bonavida, B. (1997) Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biotherapy and Radiopharmaceuticals, 12, 177-186.
6. Eder, M., Battmer, K., Kafert, S., Stucki, A., Ganser, A. & Hertenstein, B. (1999) Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia, 13, 1383-1389.
7. Freedman, A.S., Gribben, J.G., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Pandite, L., Robertson, M.J., Kroon, M., Ritz, J. & Nadler, L.M. (1996) High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780-2786.
8. Gianni, A.M., Magni, M., Di Nicola, M., Gandola, L., Lombardi, F., Datsoli, G., Matteucci, P., Devizzi, L., Bregni, M., Campana, S., Corradini, P., Pileri, A. & Tarella, C. (1998) In-vivo purging of circulating CD34+ progenitor cells in low-grade lymphoma with rituximab and high-dose therapy (Abstract). Blood, 92, 481.
9. Gribben, J.G., Neuberg, D., Freedman, A.S., Gimmi, C.D., Pesek, K.W., Barber, M., Saporito, L., Woo, S.D., Coral, F., Spector, N., Rabinowe, S.N., Grossbard, M.L., Ritz, J. & Nadler, L.M. (1993) Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B cell lymphoma. Blood, 81, 3449-3457.
10. Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Sequential high dose therapy with peripheral blood progenitor cell support in low grade non Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685-1692.
11. Haas, R., Moos, M., Mohle, R., Dohner, H., Witt, B., Goldschmidt, H., Murea, S., Flentje, K., Wannenmacher, M. & Hunstein, W (1996) High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplantation, 17, 149-155.
12. Hooijberg, E., Sein, J.J., van den Berk, P.C., Hart, A.A., van der Valk, M.A., Kast, W.M., Melief, C.J. & Hekman, A. (1995) Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Research, 55, 2627-2634.
13. Luthra, R., McBride, J.A., Cabanillas, F. & Sarris, A. (1998) Novel 5′ exonuclease-based real-time PCR assay for the detection of t (14;18) (q32;q21) in patients with follicular lymphoma. American Journal of Pathology, 153, 63-68.
14. Maloney, D.G., Grillo-Lopez, A.J., Bodkin, D.J., White, C.A., Liles, T.M., Royston, I., Varns, C., Rosenberg, J. & Levy, R. (1997a) IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 15, 3266-3274.
15. Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. & Levy, R. (1997b) IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90, 2188-2195.
16. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. & Dallaire, B.K. (1998) rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825-2833.
17. Moos, M., Schulz, R., Martin, S., Benner, A. & Haas, R. (1998) The remission status before and the PCR status after high dose therapy with peripheral blood stem cell support are prognostic factors for relapse free survival in patients with follicular non Hodgkin's lymphoma. Leukemia, 12, 1971-1976.
18. Press, O.W., Howell-Clark, J., Anderson, S. & Bernstein, I. (1994) Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood, 83, 1390-1397.
19. Shan, D., Ledbetter, J.A. & Press, O.W. (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood, 91, 1644-1652.
20. Tedder, T.F., Boyd, A.W, Freedman, A.S., Nadler, L.M. & Schlossman, S.F. (1985) The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. Journal of Immunology, 135, 973-979.
21. Voso, M.T., Hohaus, S., Moos, M. & Haas, R. (1997) Lack of t( 14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Blood, 89, 3763-3768.
22. + peripheral blood stem cells (PBSC): retained engraftment capability and reduced tumour cell content. British Journal of Haematology, 104, 382-391.
23. Voso, M.T., Martin, S., Hohaus, S., Abdallah, A., Schlenk, R.F., Ho, A.D. & Haas, R. (2000) Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy. Bone Marrow Transplantation, in press.